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ABSTRACT 
The innate immune system represents the first line of organism defense. Monocytes 
and their derivatives, the macrophages, play a central role in this response. The monocyte 
response to various stimuli is complex and includes simultaneous activation in a variety of 
ways. The common methods currently used to estimate this response usually focus on one of 
the modes of activation. The aim of this thesis was to assess the possibility of designing an 
assay based on unbiased proteome analysis that would be capable of predicting the monocyte 
response to various challenges. The underlying hypothesis of the project was that the cell 
proteome response to different activating molecules would reflect the immunogenicity of 
these molecules. 
The assay is based on comparison between the proteomes of human monocytic   
THP-1 cells treated with a stimulus of interest and the ‘reference’ proteomes obtained from 
THP-1 cells treated with positive and negative controls. The study described in Paper I 
(Project 1) revealed two main types of monocyte responses and features of monocyte 
separation into adherent and non-adherent subpopulations. The first subpopulation 
differentiated into macrophages, while the second one was activated by cytokines according 
to the changes in their proteomes compared to the control cells. The Pam3CSK4 and PMA 
stimuli were concluded to be the best positive controls for pro-inflammatory activation and 
differentiation, respectively, among the tested nine treatments (Paper II, Project 2). Anti-
cancer drugs with known mechanisms of action were chosen as positive controls for cell 
death (Paper III). The workflow of the assay was optimized and validated in Paper II (Project 
2). The established assay was applied to identify the response of monocytes to peptide 
containing isoaspartate (Paper II, Project 3) and nanoparticles (Paper III, Project 3). The 
epidermal growth factor (EGF) peptide containing isoaspartate primed monocytes for 
differentiation but not for pro-inflammatory activation. The three studied nanoparticles 
induced distinct proteome signatures despite equivalent overall toxicity effect (induction of 
50±10% cell death). The CdTe-NH2 nanoparticles induced the strongest response 
characterized by down-regulation of topoisomerases and similar to the effect of 
Camptothecin. The response to CuO nanoparticles included up-regulation of proteins 
involved in heat response. The gold nanoparticles showed the weakest response among the 
studied three nanoparticles and induced up-regulation of NF-κB and a number of proteins 
related to energy metabolism consistent with pro-inflammatory activation.  
The established and validated assay has several possibilities for extension as well as 
optimization for particular aims of the experiment. For instance, the identification of induced 
post- translational modifications upon stimulation can be performed (Paper IV, Project 4). 
Because of its versatility, robustness and specificity, this new assay is likely to find a niche 
among the more established immunological methods.  
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CHAPTER 1. BACKGROUND  
1.1. INTRODUCTION 
1.1.1. Innate immune system 
The answer to the question: ‘what would be an organism’s response to a particular 
substance?’ would include analysis of the responses of different tissues, organs and cell types 
to this compound. The immune system is the defense system of the organism and most likely 
would be the first system detecting the compound and responding to it. Information about the 
response of the immune system would be therefore valuable for understanding the initial 
response of the organism to a substance. 
The first line of immune response is the innate immune system. It triggers 
inflammation and the second line of the immune response, adaptive immunity. The Nobel 
Prize in Physiology was awarded to the strong opponents Paul Ehrlich and Ilya Metchnikoff 
in 1908 for their discovery of these two major parts of immune system, adaptive and innate 
immunity, respectively.
1,2
 Historically the distinction between these types of immunity is 
based on (1) specificity of response, (2) phase or rapidness of the response, and (3) memory 
(Table 1). The emerging information about one group of innate immune cells, the innate 
lymphoid cells (ILC), however, makes this distinction less clear. 
Table 1. Differences between the innate and adaptive immunity 
Comparison Innate immune system Adaptive immune system 
time scale fast (hours) slow first time (days)  
(fast to the secondary infection) 
phase of immune 
defense 
first second 
specificity nonspecific highly specific 
memory recent studies has indicated that it exists
3
 yes
4
 
cells monocytes, macrophages, granulocytes 
(neutrophils, basophils, eosinophils), 
dendritic cells, innate lymphoid cells (e.g., 
NK cells) 
T-cells, B-cells 
non-cellular 
components 
acute phase proteins, cytokines, 
complement proteins 
cytokines, antibodies 
specific responses molecular pattern recognition, antigen 
engulfment and presentation on cell 
surface 
antibody production against 
particular antigen 
 
1. Background 
2 
The term ‘innate immunity’ in some cases includes physical, chemical, and 
microbiological barriers, but more usually encompasses the elements of the immune system 
which provide an immediate host defense. It is highly conserved and evolutionarily older than 
the adaptive immune defense strategy, and is present even in the simplest animals and 
plants.
5,6
 The elements of the innate immune system include several types of cells (Figure 1), 
complement proteins, cytokines, and acute phase proteins (Table 1).
5
 The innate immune 
system plays an important role in the initiation of inflammation and it also has been reported 
to be able to facilitate autoimmune diseases.
7,8
   
 
Figure 1. Simplified schematic diagram of immune cell development stages (black arrows), their 
interactions, and their response to infection (red arrows), focusing on monocytes/macrophages. All 
blood cells originate from a common progenitor, the hematopoietic stem cell (HSC).  HSCs are 
located in the red bone marrow and give rise to myeloid lineages (monocytes, granulocytes, 
erythrocytes, megakaryocytes/platelets, and mast cells) and lymphoid lineages (T-cells, B-cells, and 
NK-cells). T-cells and B-cells subsequently need to pass positive and negative selection (in bone 
marrow for B-cells and in thymus for T-cells). Monoblasts migrate from the bone marrow to blood 
and become monocytes. Monocytes circulate in the blood, subsequently entering the tissue and 
differentiating into macrophages or dendritic cells. Macrophages and dendritic cells are the first 
responders to infection in tissues. They bind, engulf, digest and present parts of the foreign 
particles/bacteria to other cells. Activated T-cells transfer the signal to B-cells, which mature into 
plasma cells and start producing antibodies or develop into memory B-cells. Macrophages become 
activated by binding a danger associated molecular pattern and start producing cytokines and 
chemokines to activate and attract other cells. Macrophages also produce reactive oxygen species 
(ROS) to counteract the infection. 
Nataliya Tarasova 
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Upon an infection or damage of a tissue the first cells detecting and responding are 
the tissue resident macrophages.
9,10
 The resident macrophage populations develop from 
monocytes in the yolk sac during embryonic development and self-replenish in the tissue.
11
 
These cells represent just an initial step of infection recognition and response. Their main 
function is to maintain homeostasis and in the steady-state they have anti-inflammatory 
functions.
12
 In contrast, tissue clearance and inflammatory responses are mainly performed by 
macrophages derived from blood monocytes that upon stimulation leave the bloodstream, 
migrate into tissue and differentiate into macrophages or dendritic cells (Figure 1).
11
 
Monocytes thus act as ‘immunological orchestrators’,13 and monocyte responses to different 
stimuli can in many cases reflect the innate immune responses to various compounds. 
Monocytes were therefore selected in this thesis as representatives of the innate immune 
system. 
1.1.2. Monocytes and their responses 
Monocytes are blood cells that can morphologically be distinguished by their kidney-
shaped nucleus with mature chromatin, a low nuclear-to-cytoplasmic ratio and the presence 
of vacuoles. The average diameter of these cells is 14μm, which is about twice the size of 
erythrocytes. Monocytes belong to a mononuclear fraction of peripheral blood cells 
(peripheral blood mononuclear cells, PBMC). The PBMC can be isolated from the whole 
blood by density centrifugation. Monocytes can be purified from other PBMC by different 
approaches, one of the most common of which is based on high expression of the marker 
CD14 on their surface. 
Isolated monocytes can be maintained in culture in vitro for several months, although 
changes in their morphology and activity were observed during such long-term culture.
14
 The 
transition towards macrophages
14
 correlates with the observation that in vivo monocytes stay 
in the bloodstream for 1-3 days and then migrate into tissues
3
. There are also examples of 
immortal monocytic cell lines derived from tumors (Table 2). In addition to their immortality 
the advantages of cell lines include independence from variability between the individual 
donors and easy maintenance in culture. 
Table 2. Human monocytic cell lines derived from tumors 
Cell line Tumor Reference 
THP-1 acute monocytic leukemia Tsuchiya et al., 1980
15
 
U937 histiocytic lymphoma Sundström et al., 1976
16
 
HL60 acute promyelocytic leukaemia Gallagher et al., 1979
17
 
Mono Mac 6 Acute monocytic leukemia Zeigler-Heitrock et al., 1988
18
 
 
In the immortilised monocytic cell lines, the differentiation process from monoblast to 
monocyte is arrested. Several steps can be distinguished in the monocyte->monoblast 
differentiation: pro-monocyte, immature monocyte and mature monocyte. The differentiation 
1. Background 
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arrest in leukaemias occurs at relatively early stages of monoblast development due to the 
loss of proliferative potential in later stages of cell development.
19
 The human monocytic 
THP-1 cell line (THP-1 cells) is derived from a young male diagnosed with acute monocytic 
leukaemia
15
 and represents leukocytes stopped in their differentiation process between the 
promonocyte and immature monocyte stages. The earlier established cell lines employed for 
mimicking monocytes in vitro, such as U-937
16
 and HL-60
17
, require prior differentiation into 
monocytes.
20,21
 Even though the later established Mono Mac 6 cell line is closer in its 
properties to mature human monocytes,
18
 the THP-1 cell line is still employed in research 
more frequently. As such, THP-1 cells are considered to be one of the best models for 
monocyte-macrophage differentiation process, as well as for mimicking other monocyte 
responses.
22–25
  
As with other cells of the innate immune system, monocytes are able to recognize and 
respond to various signals of danger, initiating inflammation (Figure 1, red arrows). 
Monocytes recognize a large number of molecular patterns, which can be generally divided 
into two groups (Figure 2). The first group, PAMP (pathogen associated molecular patterns), 
include conserved structures in pathogens (e.g. lipopolysaccharides (LPS), flagellin).  The 
second group, DAMP (danger/damage associated molecular patterns), was discovered rather 
recently and includes signals originating from damaged tissue (e.g. HMGB1, HSP proteins, 
and ATP) and potential danger (e.g. silicon particles). PAMP and DAMP are recognized by 
pattern recognition receptors (PRR) on the surface of or inside the cells.
26
 The PRR protein 
family includes Toll-like receptors (TLR), for the discovery of which Jules Hoffman and 
Bruce Beutler were awarded the Nobel Prize in Physiology or Medicine in 2011. 
Table 3. Human toll-like receptors (TLR) and their ligands 
TLR Ligand 
TLR1 triacyl lipopeptides 
TLR2 peptidoglycan 
lipopeptides, lipoteichoic acid, lipoarabinomannan, GPI anchors, phenol-soluble 
modulin, zymosan, glycolipids 
TLR3 dsRNA 
TLR4 LPS, Taxol, RSV fusion protein, MMTV envelope protein, endogenous ligand (HSPs, 
fibronectin, hyaluronic acid) 
TLR5 flagellin 
TLR6 diacyl lipopeptides 
TLR7 ssRNA, imidazoquinolines 
TLR8 ssRNA, imidazoquinolines (only in humans) 
TLR9 CpG DNA 
TLR10 unknown 
 
TLR detect molecular signatures which are conserved among a large group of 
pathogenic microorganisms.
27–29
 Of the 13 currently known TLR members, 10 has been 
identified in humans (Table 3).
30
 TLRs are located both on the cell surface (TLR1, TLR2, and 
TLR4-TLR6) and inside of cells. Each TLR recognizes a particular PAMP (Table 3). Ligand 
Nataliya Tarasova 
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binding to TLR initiates signaling cascades. The TLR signaling pathways consist of two 
major cascades depending on TIR domain–containing adaptors (MyD88 or TRIF). MyD88 
mediates activation of NF-κB via all TLRs, except for TLR3, leading to the induction of 
inflammatory cytokine genes. TRIF mediates TLR3- and TLR4-dependent activation of IRF3 
and NF-κB, inducing IFN-β production.30 This leads to changes inside the cell (Figure 2), 
including post- translational modifications (PTM), increase/decrease in enzymatic activity, 
gene transcription, protein degradation and synthesis. These events in turn result in release of 
inflammatory mediators and the activation of the adaptive immune system, e.g. T-cells. 
Apart from released inflammatory mediators, T-cells can be activated by antigens 
presented on the surface of monocytes bound to the MHC (major histocompatibility 
complex). The intracellular antigens are degraded in the proteasome, the degradation products 
are transferred to the endoplasmic reticulum and with aid of the TAP1/TAP2 complex, and 
loaded into the groove of MHC class I molecules. The antigen peptide bound to MHC class I 
is subsequently recognized by CD8
+
 T-cells. MHC class I is ubiquitously expressed in all 
cells of an organism and is required for the cell to be recognized as a part of the organism. 
The external engulfed foreign molecular patterns (antigens) are digested in lysosomes and 
presented by the MHC class II to CD4
+
 T-cells (Figure 2). The MHC class II is expressed at 
high levels in a subset of the immune cells that are hence referred to as antigen presenting 
cells (APC). 
 
Figure 2. Simplified schematic diagram of molecular mechanisms of responses of antigen presenting 
cells with focus on events with proteins. Pathogen and damage/danger associated molecular patterns 
(PAMPs and DAMPs, respectively) are recognized by pattern recognition receptors (PRR; e.g. TLRs 
or NLRs) on the surface of or inside the antigen presenting cells. Extracellular antigens are engulfed, 
digested in endosomes and presented in complex with MHC class II (protein antigens) or CD1 (lipid 
antigens) to CD4
+
 T-cells. Intracellular antigens are presented on the surface of the cell in a complex 
with MHC class I to CD8
+
 T-cells. Antigen binding to PRR triggers an activation cascade in cells that 
transfers the signal to the nucleus. This leads to synthesis of new proteins, cytokines and ROS release, 
and activation of other signal cascades. 
 
1. Background 
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Monocyte responses include multiple processes and changes in the cells at all levels, 
from genome to proteome and secretome, and can eventually lead to cell differentiation or 
death (Figure 2). These responses and changes in the cells can be qualitatively characterized 
using a number of methods (e.g. RT-PCR, reverse transcriptase–polymerase chain reaction; 
immunohistochemistry). Monocyte responses can be also quantified and estimated using 
different methods, such as real-time polymerase chain reaction (qPCR or quantitative PCR), 
flow cytometry, enzyme-linked immunosorbent assay (ELISA), and kinetic studies. 
1.1.3. Methods to study monocyte responses 
The methods currently used to study monocyte responses can be divided into two 
large groups: focused and broad-based approaches (Table 4). 
Table 4. Comparison between focused and broad-based approaches 
 Focused approach Broad-based approach 
Goal understanding the specific protein/gene 
regulation 
understanding the system behavior 
(proteome, genome) 
Pros • less expensive, quick 
• can be more sensitive 
• precise, hypothesis-driven 
• does not require expensive equipment 
• many samples in parallel can be 
analysed 
• information about a specific tissue/cell 
type under certain conditions 
• relationships between a large number of 
molecules 
• hypothesis-generating 
Cons • information about the target is 
required prior to analysis 
• hard to study global relationships 
between a large number of molecules 
• more expensive and time-consuming 
• extensive planning is required in advance 
• more expensive equipment 
• fewer samples can be analysed 
 
1.1.3.1. Focused Approaches 
The focused approaches currently dominate in immunology (Table 5), potentially due 
to their low price and demands on instrumentation as well as availability and variety of this 
type of kits and assays. Their results are also quite easy to analyze and interpret. Depending 
on which type of cell response (e.g. cytokine release, surface marker expression) and cell 
compartment is studied, different approaches can be applied. 
The cell responses include protein degradation as well as synthesis of new proteins. 
The changes synthesis of new proteins upon cell activation can be due to alterations on 
translational as well as transcriptional level. One of the ways to observe changes in gene 
expression is RT-PCR. The complimentary DNA (cDNA) molecules can be obtained from 
RNA template molecules with the reverse transcriptase enzyme. The cDNA molecules can 
then be amplified by PCR, the technology being based on DNA replication.
31
 The typical 
cycle of PCR process includes three main steps: (1) denaturation of DNA, (2) annealing of 
the selected/designed primers, (3) elongation of new DNA strand. This cycle is repeated 20-
40 times, resulting in thousands of copies of particular DNA molecule(s). If the PCR reaction 
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is monitored in real time, the number of RNA copies also can be determined, which is a basis 
of the qPCR method. 
Table 5. Comparison between targeted approaches frequently used in immunology 
Method Cell response Target type 
Target 
identification 
Quantification basis 
RT-PCR gene 
expression 
RNA primer 
real time PCR monitoring 
(qPCR) 
western blot protein level 
regulation 
protein/PTM antibody 
western blot signal 
flow 
cytometry 
surface 
markers 
usually protein antibody 
particle counts 
ELISA cytokines usually protein antibody light intensity 
Luminex cytokines 
protein antibody 
bead counts and intensity of 
florescence 
 
Proteins can be identified and quantified from complex mixtures using western 
blotting. In western blotting proteins are separated by gel electrophoresis, transferred to a 
solid support and the target protein is detected by primary and visualized by secondary 
antibodies conjugated to a fluorophore or enzyme.
32
  
In flow cytometry, the cells of interest are first labeled with fluorescent markers, 
which are usually antibodies against specific cell surface proteins conjugated with 
fluorophores. In the cytometer the stained cell sample in a suspension buffer is 
hydrodynamically focused with the aid of a small nozzle, which allows cells to pass the laser 
light one at a time. Each suspended particle or cell passing through the beam scatters the 
light. The detectors can measure various parameters of light scattering by a single cell. One 
detector is placed in line with the light beam to measure forward scatter (FSC) and this 
correlates with the cell size. Several perpendicular detectors can measure side scatter (SSC) 
that depends on the inner complexity of the particle (i.e. shape of the nucleus, the amount and 
type of cytoplasmic granules or the membrane roughness). The data from the light scattering 
can be plotted using 2D plots (FSC vs SSC) to visualize different cell populations in the 
sample. The detection of fluorescent labels on the surface of the cells can be used to 
differentiate between cell types. The number or percentage of the cells expressing the marker 
of interest on its surface can be used to characterize a cell population. With some 
modifications to the procedure, flow cytometry can be also applied to detect intracellular 
proteins, including cytokines in cells. 
Extracellular cytokines released from the cells are commonly analyzed using ELISA 
(enzyme-linked immunosorbent assay). The ELISA is a plate-based method that allows 
detection and quantification of various molecules. In a standard ELISA the antigens from the 
sample are attached to a surface. Specific antibody is applied over the surface so that it can 
bind to the antigen. This antibody is linked to an enzyme, which transforms a substrate into a 
detectable signal. Most commonly the signal is colorimetric. Indirect ELISA employs 
1. Background 
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labelled secondary antibody that binds to the primary antibody and increases the sensitivity of 
the method as well as improving immunoreactivity of the primary antibody. Sandwich 
ELISA is the most powerful assay format with the advantages of being sensitive and robust. 
It is called sandwich because the analyte is bound between two primary antibodies, the 
capture and the detection antibodies, respectively. The sandwich ELISA-like assay called 
ELISPOT (enzyme-linked immunospot assay) allows capturing the proteins locally as they 
are secreted by plated cells. 
The Luminex technology is based both on ELISA and flow cytometry and allows the 
detection of multiple cytokines simultaneously. It is based on color- and size-coded 
polystyrene or superparamagnetic beads coated with analyte-specific antibodies. Beads 
recognizing different cytokines are mixed together and incubated with the sample. Captured 
analytes are subsequently detected using biotinylated secondary antibodies and a streptavidin-
phycoerythrin (PE) conjugate. The polystyrene beads are usually analyzed using a dual-laser 
flow-based detection instrument. One laser classifies the bead and determines the analyte that 
is being detected. The second laser determines the magnitude of the PE-derived signal, which 
corresponds to the amount of the bound analyte. Luminex technology is a step towards 
multiplex analysis, but it is still based on detection of specific known analytes. Omics 
methods are able to solve this issue, representing unbiased, broad-based and hypothesis-
generating methods. 
1.1.3.2. Broad-based approaches 
The broad-based approaches are also called omics methods, because their names end 
with ‘-omics’: genomics, transcriptomics, proteomics, metabolomics. Depending on which 
part of the central dogma of biology is explored, different omics techniques are applied 
(Figure 3). Genomics studies entire DNA content of the cell and gives a possibility to predict 
what is going to happen in the cell. What cells intend to do is encoded in RNA molecules, 
studied by transcriptomics methods. Proteomics, the simultaneous analysis of the entire 
protein population, allows the identification of what is happening in a cell. Finally, 
metabolomics mainly studies what has happened inside a cell, i.e. the metabolic products o 
proteins’ enzymatic activity. Our focus was on the proteomics approaches, which give 
information about the current situation inside a cell. We believe that this approach is the best 
for estimating the response of the cells, including monocytes. 
 
Figure 3. Central dogma of biology and ‘Omics’ methods to study each part of it. 
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Proteomics 
The word ‘proteome’ was first used to describe the protein complement of an 
organism’s genome and later gave a rise to a new discipline ‘proteomics’.33 Proteomics can 
largely be divided into functional, structural and differential proteomics.
33,34
 Functional 
proteomics identifies protein-protein, protein-DNA or protein-RNA interactions affecting 
particular functions. Structural proteomics characterizes interactions of proteins with metal 
ions, toxins, drugs, etc. affecting the protein structure. Differential, or protein expression, 
proteomics determines the differences in concentration levels, which depend on protein 
expression and degradation. Historically, differential proteomic analyses have relied on two-
dimensional polyacrylamide gel electrophoresis (2D PAGE).  
In 2D PAGE proteins are separated by isoelectric focusing in the first dimension and 
SDS-polyacrylamide gel electrophoresis in the second one. While isoelectric focusing 
separates proteins according to their isoelectric points (pI), SDS-polyacrylamide gel 
electrophoresis separates them according to their molecular weights. The final result of the 
2D PAGE is a map with proteins focused into spots, which can be subjected to further 
analysis using mass spectrometry (MS).
35
 Proteins can be also directly analyzed with MS 
without prior gel separation. 
The measurements in mass spectrometry are performed in the gas phase on ionized 
analytes. A mass spectrometer consists of an ion source, a mass analyzer that measures the 
mass-to-charge ratio (m/z) of the ionized analytes, and a detector that registers the number of 
ions at each m/z value. Electrospray ionization (ESI) and matrix-assisted laser 
desorption/ionization (MALDI) are most commonly used to volatize and ionize the proteins 
or peptides for mass spectrometric analysis.
36,37
 ESI ionizes the analytes out of a solution and 
can therefore be coupled to liquid-based (chromatographic) separation devices. MALDI 
sublimates and ionizes the samples out of dry crystals with matrix via laser pulses. MALDI is 
usually used for the analysis of relatively simple protein/peptide mixtures, while integrated 
liquid-chromatography ESI systems (LC-MS) are more suitable for the analysis of complex 
samples.
38
 The most commonly used mass analyzers for proteomics are: quadrupoles (Q), 
radiofrequency ion traps (quadrupole ion trap, QIT an linear ion trap, LIT or LTQ), time-of-
flight (TOF) mass analyzers, and Fourier-transform (FT) mass analyzers, such as electronic 
FT Orbitrap or magnet-based FT ion cyclotron resonance (FTICR) mass analyzers.
39
  
There are two mail approaches for protein identification and characterization.
40
 In the 
first one, top-down approach, intact proteins or large protein fragments are analyzed. The 
alternative approach, bottom-up, is to analyze peptides generated by enzymatic cleavage of 
proteins. When bottom-up approach is applied to a mixture of the proteins it is called shotgun 
proteomics method (analogous to shotgun sequencing of DNA).
41
 Trypsin, which cleaves on 
the C-terminal side of lysine and arginine residues, is a commonly used protease in bottom-
up approach. Digestion with trypsin results in peptides of an appropriate length and generates 
spectra that are easy to interpret due to basic groups in both ends of the peptide: the free 
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amine group on N-terminus and either Lys or Arg on C-terminus. Peptides can be identified 
by peptide mass fingerprinting (PMF) or tandem mass spectrometry (MS/MS). In PMF, the 
masses of individual peptides in a mixture are measured in mass spectrum. In MS/MS, 
peptides are selected by a mass analyzer are fragmented into smaller pieces, with the masses 
of latter detected, which can be used to deduce the amino acid sequence of the peptide 
(Figure 4). This technique is more powerful and allows identification of the types and sites of 
peptide/protein modifications. The combination of LC with the bottom-up MS/MS approach 
is the most common incarnation of the shotgun proteomics.
42
 Mass spectra derived from 
peptide fragmentation are compared to theoretical tandem mass spectra generated from in 
silico digestion of a protein database. The identified peptides are assigned to proteins. 
 
Figure 4. Scheme of tandem mass spectrometry and types of peptide fragmentation. Following 
ionization, precursor ions are selected at the mass selection stage (MS1) that are subsequently 
fragmented. The product ions are selected in the MS2 stage. Additional stages of selection and 
fragmentation can be performed before fragment ion detection. Peptide backbone fragmentation and 
nomenclature of formed fragments is presented in the insert in the right upper corner.  
 
In addition to protein ID’s the data can be used for quantification. Though there are 
number of MS-based methods for absolute quantification (e.g. AQUA), most techniques are 
based on relative quantification. Relative quantification can be performed with or without 
labelling. The labelling techniques employ metabolic labelling at cellular or tissue levels 
(SILAC), chemical (ICAT, iTRAQ, TMT) or enzymatic (H2
18
O) labelling at protein or 
peptide levels. Samples are merged after the labelling, which decreases the technically-
induced variation between them. 
The advancement in LC-MS equipment during the last decades together with the need 
to analyze larger and larger sample sets has increased the interest in label-free techniques. 
Label-free proteomics approaches can be divided into two groups by the way that the 
abundance of a peptide is measured. The first group includes methods that are based on ion 
counting. These methods compare either maximum abundance or volume of ion count for 
peptide peaks at specific retention times between different samples. The second group is 
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based on the identification of peptides by MS/MS and uses sampling statistics such as peptide 
counts, spectral counts, or sequence coverage to quantify the differences between samples.
43
  
The studies in this thesis has relied on shotgun and label-free proteomics.
42
 The 
common shotgun label-free proteomics workflow can be divided into a few general steps 
(Figure 5). The first step is common for all experiments, but is more important in the case of 
broad-based approaches compared to focused ones. This step includes the development of a 
hypothesis specific to the proteome being studied, selection of the most suitable technique 
among those described above and selection of comparable controls and samples. The 
following technical steps are (1) cell/organism treatment and sample collection, (2) sample 
preparation for MS analysis, (3) MS data acquisition, and (4) MS data in silico analysis.  
 
Figure 5. Common workflow for label-free shotgun proteomics to study the effect of cell treatment. 
 
Proteomics data analysis requires quality control of the obtained and a correct choice 
and application of statistical analysis methods.
44
 The number of proteins is normally greater 
than samples. Methods to analyze for data with multiple variables (multivariate analysis) are 
developed for such data sets.  
These methods include principle component analysis (PCA), partial least squares 
(PLS), orthogonal projections on latent structures (OPLS) and various clustering methods. 
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The PCA analysis is a widely applied method for reduction of dimensions of complex data to 
reveal the potentially hidden, simplified dynamics that often underline it.
45
 The PLS and 
OPLS methods are supervised versions of the PCA method, where the main variable or 
groups are defined, respectively. The position of sample on PCA plot represents a 
‘fingerprint’ of the stimulus it was exposed to. Proteins affected by the treatment and 
therefore responsible for the position of the sample on PCA plot can be identified and further 
investigated as markers for the stimulation. The significance of up- or down-regulated 
proteins can be identified using T-test or other types of univariate analysis with correction for 
multiple testing (e.g. Bonferroni correction and false discovery rate) to avoid false positives 
due to the multiple testing. The proteins of interest identified in these analyses can be mapped 
to known cellular pathways or processes. 
In summary, MS-based proteomics is a powerful unbiased approach to identify 
changes in cells occurring upon treatment. 
 
 
1.2. PURPOSE AND HYPOTHESIS OF THE THESIS 
The purpose of the thesis was to generate an unbiased approach based on proteomics 
able to assess complex monocyte responses. We aimed to design an assay based on 
proteomics of THP-1 cells that is able to estimate the biological effect of various challenges 
on monocytes. The hypothesis underlying the project was that different monocyte-activating 
compounds will trigger qualitatively different proteome responses that can be distinguished 
using label-free MS-based proteomics. 
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1.3. LITERATURE REVIEW 
The current advances and knowledge of the project’s topic are summarized in this 
chapter. The purpose of the thesis was to design a monocyte-based proteomics assay. The 
first part of the literature review is focused on aspects of assay development and different 
versions of biological assays. The second part of the review is focused on summarizing the 
results of proteomics studies of THP-1 cells.  
 
1.3.1. Assays 
An assay is a standardized procedure for qualitative assessment or quantitative 
measurement of the presence, amount or the functional activity of a target entity, the analyte. 
Originally in the 13
th
 century the word ‘assay’ was used in the phrase assay the coin that 
meant to analyze the purity of a gold or silver coin. Later it was generalized to analytical 
procedures with other types of analytes. The analyte in biological assays for example can be a 
drug, biochemical substance or a cell. Currently there is a large variety of biological assays 
available, and their numbers are rapidly increasing. However, assays usually include a 
number of common steps, such as sample processing and manipulation, signal amplification, 
detection and discrimination from background. 
The common procedure to establish an assay often also consists of several steps, 
starting with development and optimization, followed by validation and end with custom 
adjustment depending on the particular experiment. Establishment as well as application of 
each assay requires assessment of its quality. The number of assay characteristics can be 
employed as a basis to evaluate its quality, most important of which are sensitivity, 
specificity, reproducibility, area of applications and limitations.  
A high reproducibility is required for a successful assay. This can be assessed through 
analysis of replicates within an experiment or using similar samples in different experiments. 
The specificity and sensitivity are interconnected and an increase in one often leads to a 
decrease in the other. The sensitivity (true positive rate) characterizes the assay’s ability to 
detect an analyte in the sample, while specificity (true negative rate) relates to the assay’s 
ability to distinguish it from other signals. The sensitivity depends on the detection limit. For 
an individual analytical procedure the detection limit is the lowest amount of analyte in a 
sample that can be detected. The limitations and area of application of each assay are defined 
by these characteristics as well as the type of assay.  
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There are different ways to classify assays:  
 number of analytes studied (single analyte or multiplex assay) 
 assay principle (e.g. response of cells, organisms etc) 
 target being measured (protein, DNA, RNA, or other molecules) 
 type of the result produced (quantitative, semi-quantitative, or qualitative) 
 nature of assay process (end-point assays with detection at fixed time point or 
dynamic with detection on-line or at set of time points) 
 detection methods 
The assay that was established in this study is a semi-quantitative multiplex assay 
based on changes in protein abundances as a result of the cellular response (THP-1 cells) to 
stimulus. The assay can be applied as both an end-point and a kinetic assay. The MS-based 
label-free proteomics approach was selected as a detection method for the assay in the 
project.  
1.3.2. Proteomics of THP-1 cells 
The THP-1 cell line has been sucessfully employed for more than 30 years in 
hundreds of studies, including over 50 proteomics studies. Starting from the beginning of the 
century the number of the publications has been increasing exponentially (Figure 6). The 
years 2009 and 2015 are outliers, when the number of publications exeeded that predicted by 
the exponential curve, and this could be explained by rapid development of proteomics 
methods as well as increased interest in macrophages and monocytes within the 
immunological research community prior to these years.  
 
Figure 6. Number of publications per year that employ THP-1 cell line as a research tool and 
proteomics as a method. The studies where the THP-1 cell line was used at the confirmation step were 
also included. 
 
Nataliya Tarasova 
 15 
Proteome changes upon THP-1 monocyte activation have been investigated in a 
number of studies. Monocytes can be activated by external (foreign) stimuli such as bacteria 
or their fragments (‘6’ in Figure 7).46 Other sources of monocyte activation are internal 
signals, like immunogenic proteins/peptides (‘4’ in Figure 7),47 hormones (‘5’ in Figure 7) or 
deviations in extracellular conditions from homeostasis (e.g. high glucose)
48
. Internal signals 
are a necessity for appropriate communication between cells and cooperative reactions to 
infections. The signals produced by monocytes, including the secreted ones (secretome), have 
also been studied using proteomics methods.
49,50
 
 
Figure 7. A summary of protemics studies of THP-1 cells is presented. THP-1 cells combine 
properties of monocytes and leukemic cancer cells. Differentiated monocytes are also often used as a 
model for macrophages. Both monocytes and macrophages can be activated by stimuli or extracellular 
conditions deviating from homeostasis (e.g. high glucose, hypoxia). Different sources of activation 
stimuli are presented. Macrophages can also be polarised into pro- and anti-inflammatory 
macrophages. THP-1 cells can model acute myeloid leukemia and were used to study the effect of 
treatments against leukemia. 
 
THP-1 activation has been demonstrated to induce changes in the abundance of 
stress-associated proteins, including up-regulation of heat shock proteins and the 
proteasome.
51,52
 Apart from the set of general stress-induced proteins, unique up- and down-
regulated proteins related to the immune response were also identified for each stimulus. For 
example, cyclophilin is up-regulated in response to bacterial GpG DNA
51,
 or HMGB1 and 
LCP1 are characteristic for cytokine activation (IL-1β and TNF-α)52. 
The THP-1 cell line has been successfully applied in proteomic studies, not only as a 
model of monocytes (section 1.1.2), but also for mimicking its derivatives, macrophages and 
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dendritic cells. There are also examples whereby THP-1 cells have been employed for 
modelling microglia
50
 (resident myeloid cells in the central nervous system analogous in 
function to monocytes) or foam cells
53
 (fat-laden macrophages which play a critical role in 
the occurrence and development of atherosclerosis).
54
 About half of the proteomics studies 
employ macrophages derived from THP-1 cells, also termed ‘THP-1 macrophages’. A trend 
can be observed over the years with the interest shift from THP-1 monocytes to THP-1 
macrophages. THP-1 macrophages behave more like primary monocyte-derived 
macrophages compared to other human myeloid cell lines.
22
 The standard method for THP-1 
differentiation into macrophages is incubation with phorbol 12-acetate 13-myristate (PMA). 
Other inducers of THP-1 differentiation into macrophages include retinoic acid,
55
 
lipopolisacharide (LPS),
56
 and 1,25-dihydroxyvitamin D3
57
.  
PMA is an artificial leukocyte differentiation signal and a substance originally 
purified from plants. PMA penetrates through the membrane and activates the enzyme 
protein kinase C (PKC) inducing signal transduction cascade. The effects of PMA on PKC 
result from its similarity to one of the natural activators of PKC, diacylglycerol.
58
 The 
concentration of PMA used in the publications varied in the range 6-200 ng/mL, but the most 
frequently used concentration is about 50 ng/mL. The incubation time also varies between 12 
and 120 h, with 48 h being the most common. In a number of investigations THP-1 
macrophages after PMA stimulation were left resting in fresh media for 24 h prior to intended 
stimulation,
38,59–62
 allowing cells to proceed further along the differentiation process
63
. THP-1 
macrophages have been compared with macrophages derived from primary monocytes or 
with tissue macrophages 
63
, but not in proteomic studies. 
The study perfomed by Kristensen and collegues
64
 revealed the proteomics signatures 
of THP-1 differentiation induced by PMA. Differentiation is a process that requires structural 
and metabloic changes in cells that correlates with up-regulation of the proteins belonging to 
cytoskeleton, cell adhesion and junction processes, or cell membrane. The integrin family of 
the proteins is up-regulated during this process. Conversely, DNA replication and 
chromasomal processes are down-regulated upon differentiaiton. That fact correlates with the 
decrease of the proliferative ability of the cells and its almost complete loss at the terminal 
differentiation stage. Moreover, this study uncovered an interesting fact that during the 
differentiation the protein degradation rate remains constant while the synthesis rate 
increases. This observation reveals one feature of the differentiation mechanism that the less 
energy-efficient but better controlled way of changes in cell proteome is preferred. 
THP-1 macrophages differentiated via PMA stimulation were involved in studies 
that revealed the macrophage responses to different stimuli, such as microorganisms (e.g. 
Leishmania donovani,
65
, Campylobacter,
60
 and Porphyromonas gingivalis
66
) or specific 
compounds and complexes (e.g. TLR ligands
51
 or oxidized low density lipoproteins
24,67
). 
The stimulation effects include up-regulation of the proteins associated not only with 
immune function
60
, but also with key metabolic pathways
60,65
 and cytoskeleton
66
. The 
effects of conditions such as hypoxia have also been studied in THP-1 macrophages. 
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THP-1 cells have a dual functionality and can also be investigated as leukemic cells 
(‘3’ in Figure 7). The THP-1 cell line originates from leukocytes of a boy diagnosed with 
acute monocytic leukemia,
15
 a type of acute myeloid leukemia (AML) and a cancer of the 
myeloid leukocyte lineage. Thus THP-1 cells combine properties of myeloid cells as well as 
cancer cells (Figure 7). A few proteomic studies employed the THP-1 cell line in order to 
model leukemia.
68–70
 Aasebo and colleagues used super-SILAC mix and THP-1 cells together 
with a number of other AML-derived cell lines to create an internal standard for quantitative 
shotgun studies.
33
 The internal standard was designed to approach the problem with strong 
heterogeneity of proteomic samples from patients with AML, which in turn makes their 
quantification challenging. 
One of the potential approaches for treatment of AML patients was developed with 
the aid of THP-1 cells and a proteomics approach (‘10’ in Figure 7).69 The mitogen-activated 
protein kinase (MAPK) pathway was identified to be aberrant in leukemic cells from AML 
patients.
69
 The mechanism of MAPKK1/2 (MEK) inhibition, found to decrease AML cell 
survival, was studied in THP-1 cells using a proteomics approach. These findings gave the 
insight that MEK inhibition should be combined with VEGFR-2 inhibition to block the 
escape route of the leukemic cells. 
Surfactant protein D (SP-D) was proteomically tested in leukemic cell lines, including 
THP-1, as a drug against AML (‘11’ in Figure 7).70 This proteomic analysis elucidated the 
underlying mechanisms of rhSP-D-induced apoptosis, highlighting a decreased expression of 
proteins related to survival (such as HMGA1), upregulation of proteins protecting the cells 
from ROS, and a decrease in the mitochondrial antioxidant defense system. 
In summary, THP-1 cells have mainly been employed in proteomics studies as 
models of monocytes or macrophages. However, a few investigations used them as models of 
other myeloid cells as well as cancer cells. The proteomics findings revealed features of THP-
1 monocyte and THP-1 macrophage activation as well as of transition process between these 
cell types.  
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CHAPTER 2. PRESENT INVESTIGATIONS 
2.1. AIM AND GOALS OF THE THESIS 
The aim of the thesis was to design an in vitro assay based on unbiased proteome 
analysis that would be capable of predicting the complex response of the innate immune 
system to various challenges.  
 
The specific goals within the project were to: 
1. Identify the proteome differences between the cell subpopulations following THP-
1 cell treatment with LPS 
2. Establish the assay:  
a. Establishing the assay workflow 
b. Finding the best positive controls 
c. Validating the assay: finding the best suitable treatment concentration and 
the time of inoculation 
3. Apply the assay to assess the effects of the following substances on THP-1 cells: 
a. Isoaspartate-containing peptide 
b. Nanoparticles (CdTe-NH2, Au-20-NH2, CuO) 
4. Investigate possible extensions of the assay and identify the citrullinated sites in 
the proteins using label-free proteomics 
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2.2. OVERVIEW OF THE STUDY AND CORRESPONDING PAPERS 
The results of the thesis can be divided into four subprojects corresponding to the 
goals, which are summarized in Scheme 1. The subprojects will be referred to as Project 1-4 
and are described in more detail in the section 2.4 Results and Discussion in this chapter. The 
results of the projects were included in the papers and the manuscripts listed above and are 
depicted on the right hand side of Scheme 1.  
 
Scheme 1. The four goals of the thesis (section 2.1) and the main results of the project. The results are 
described in Papers I – IV included the thesis. The papers in the manuscript form are marked in Italics 
(Paper II is submitted to Journal of Proteome Research). 
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2.3. MATERIALS AND METHODS 
This section summarizes the details of the proteomics experiments performed to 
establish and apply the assay (Scheme 1, Project 1-3). The details of the experiments in 
Project 4 (Scheme 1) are described in Paper IV. The numbers of the projects mentioned in 
this section are corresponding to Scheme 1. 
Cell culture, harvesting and protein extraction 
In all the experiments the human monocytic cell line THP-1 (ATCC) was employed. 
The cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated 
fetal bovine serum (Biochrome, Merck Millipore), 0.05 mM mercaptoethanol, 2 mM L-
Glutamine and 100 U/mL penicillin-streptomycin mixture at 37 ºC. The experiments were 
performed in plates or flasks with ‘traditional Tissue Culture surface’ from Sarstedt. 
Nonadherent THP-1 cells were used at the initiation of all experiments. The cells in 
suspension were collected first. The cells remaining adherent were incubated for 5 min with 
0.05% trypsin mixed with EDTA and phenol red (Gibco) before collection. Collected cells 
were counted using a TC10 cell counter (BioRad) with trypan blue staining. After 
centrifugation (6-7 min; 1,000 × g), the cell pellets were washed with PBS and lysed in a 
lysis buffer (8 M urea in 100 mM ammonium bicarbonate, with or without 50 mM NaCl) 
by sonication on ice. The sonication was performed in one of two ways: (1) 21 s, in three 
repeats with breaks in between (Projects 1, 2, 3a); or (2) 40 s with pulses (5 sec on/5 sec 
off), in two repeats with a break in between (Project 3b). The latter achieved almost twice 
the amount of protein per cell. 
Protein isolation and digestion 
Cell lysates were centrifuged (20 min; 20,800 × g; 8 ºC), and supernatants were 
collected. The protein concentration in the supernatants was determined using the BCA kit 
(Pierce). Following reduction (5 mM dithiothreitol, 37°C, 30 min) and alkylation (14 mM 
iodoacetamide, RT, 30 min), 10 µg of proteins were digested by serine protease trypsin 
(Promega) at a 1:30 trypsin:protein concentration ratio (37 ºC, overnight). Digestion was 
stopped with formic acid (FA; final concentration 5-7%). Digests were desalted with C18 
StageTips (Thermo Scientific; following the manufacturers’ instructions), dried, and 
resuspended in 0.1% FA with or without 2% ACN prior to analysis. In Project 3a, in which 
only adherent cells were analyzed, acetone precipitation was performed prior to digestion. 
The acetone precipitation was done at -20 ºC in 90% pre-chilled acetone solution (v/v) for 3 
hours, followed by centrifugation (20 min; 20,800 × g; 8 ºC), acetone removal and 
evaporation of the remains of acetone and dissolving the pellet in the lysis buffer. 
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Mass Spectrometry 
LC-MS/MS analyses were performed using a nanoflow HPLC (high-performance 
liquid chromatography) directly coupled online to a Q-Exactive mass spectrometer (both 
Thermo Scientific, Germany). For each sample, 1 or 2 µg were injected from a cooled 
autosampler onto an fused silica tip column (SilicaTips™, New Objective Inc., USA) 
packed in-house with C18-AQ ReproSil-Pur® (Dr. Maisch GmbH, Germany). Mass spectra 
were acquired with a resolution of 70,000. The data-dependent MS/MS spectra were taken 
using HCD with the collisional energy of 25. Samples were analyzed in a randomized 
order. 
Protein Identification and Quantification 
MS/MS data were searched against the concatenated version of the 
UniProtKB/Swiss-Prot or UniProt complete proteome database using the Mascot search 
engine (Matrix Science Ltd., UK; www.matrixscience.com). The following parameters 
were used: trypsin digestion with a maximum of two missed cleavages; 
carbamidomethylation (C) as a fixed modification; pyroglutamate (Q), oxidation (M) as 
variable modifications; a precursor mass tolerance of 10 ppm and a fragment mass 
tolerance of 0.25, 0.1 or 0.02 Da. The list of identified proteins was filtered using 1% false 
discovery rate (FDR) and at least two peptides per protein as limiting parameters. Label-
free quantification was performed using the in-house developed program Quanti that 
compensates in silico for electrospray current fluctuations.
71
 Further details and results of 
the analyses are provided in the papers. In total, between 1,595 and 3,289 proteins were 
quantified in each experiment with at least two unique peptides per protein. 
Bioinformatics and Statistical Analysis 
Protein abundances were normalized with the assumption that equal amounts of 
protein digests were injected for each sample. Proteins that likely originated from the media 
(serum albumin and hemoglobin) or sample handling (keratins) were excluded from the 
results. Log transformed abundance values were used for further analysis. Principal 
component analysis (PCA) and Orthogonal Projections to Latent Structures (OPLS) were 
performed using the Simca software (Umetrics). Unpaired Student’s t-test with equal or 
unequal variance (depending on the result of Excel F-test) was applied to calculate the p-
values. FDR (Benjamini-Hochberg)
72
 adjusted or Bonferroni adjusted p-values (q- and E-
values, respectively) with a threshold of 5 % were used to identify significantly up/down-
regulated proteins and pathways. Pathway analysis was conducted using String 
(http://string-db.org/). The q-values for Gene Ontology (GO) terms enrichment were 
calculated by comparing to the dataset with all identified proteins. The fold change was 
calculated as a logarithm of ratio between the average relative abundance of a protein in 
treated cells and corresponding control cells.  
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The quality control of proteomics data was performed in several ways: (1) the 
retention times of peptides were compared for consistency among different samples within 
the same experiment and the samples not fulfilling the criterion were excluded from the 
experiment; (2) whether protein abundances correlated with the order of injection was 
assessed and the proteins fulfilling the criterion were excluded from an experiment; (3) 
PCA plots were analyzed for the presence of outliers. The strong outliers not grouping with 
other biological replicates were excluded from the experiment; (4) proteins quantified in 
less than 80% of experiments were excluded from the analysis. 
Treatments  
Table 6. Components applied to stimulate THP-1 cells 
Treatment 
Description/ structure 
(origin unless synthesized) 
Diluent Concentration 
LPS Lipopolysaccharide (E. coli) PBS 20, 35, 100, 500 or 
800 ng/mL 
CpG DNA 5’-tcgtcgttttgtcgttttgtcgtt-3’ Water 0.01 μg/mL 
HKLM Heat Killed Listeria monocytogenes (L. 
monocytogenes) 
Water 10
8
 cells/mL 
Flagellin Principal component of bacterial flagella 
(Salmonella typhimurium) 
Water 1 μg/mL 
Zymosan Glucan with repeating glucose units 
connected by β-1,3-glycosidic linkages 
Ethanol 10 μg/mL 
FSL-1 (Palmitoyl)2-CGDPKHPKSF Water 1 μg/mL 
Pam3CSK4 (Palmitoyl)3-CSK4 Water 0.1, 0.5 or 
2.5 μg/mL 
ssRNA 5’-GCCCGUCUGUUGUGUGACUC-3’ Water 1 μg/mL 
PMA Phorbol 12-myristate 13-acetate (12-O-
tetradecanoylphorbol-13-acetate) 
DMSO 0.01 μg/mL 
N-cont.EGF 
peptide (N) 
NSDSEGPLSHDGYGLHDGV DMSO 0.15 μg/mL 
D-cont. EGF 
peptide (D) 
DSDSEGPLSHDGYGLHDGV DMSO 0.15 μg/mL 
IsoD-cont. 
EGF peptide 
(IsoD) 
isoDSDSEGPLSHDGYGLHDGV DMSO 0.15 μg/mL 
CdTe-NH2 cadmium telluride nanoparticles coated with 
amine group  
PBS 5 μg/mL 
CuO cuprum oxide nanoparticles  PBS 22 μg/mL 
Au-20- NH2 gold nanoparticles 20 nm in diameter coated 
with an amine group 
KCl 
50 mM 
15 μg/mL 
Camptothecin anti-cancer drug, alkaloid DMSO 50 μM 
Doxorubicin anti-cancer drug, anthracycline DMSO 30 μM 
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2.4. RESULTS 
2.4.1. Project 1. Monocyte adhesion, activation and differentiation (Paper I) 
The pilot experiment with pro-inflammatory stimuli led to the observation that THP-1 
cells separate into two subpopulations after the treatment. One fraction of the cells adhered to 
the surface of the culture dish while the other remained in suspension. Adherent cells were 
detected in  untreated cell population though were present at much lower fraction of the cells 
compared to treated cell population (Paper I, Figure 1C). The observations are consistent with 
the fact that in vivo monocytes are able to adhere to the surface of blood vessels and migrate 
into tissue, and that this process is enhanced during inflammation.  
The separation of cells into subpopulations does not affect measurements in media 
(e.g. cytokines or ROS), but has a great influence on the results of the methods analyzing the 
cellular content, such as proteomics. The question about the difference between cell 
subpopulations is also important for macrophage-based immunotherapy. Monocytes can be 
differentiated and activated into pro-inflammatory macrophages that might be employed in 
tumor immune therapy. We hypothesized that proteomes of adherent and non-adherent 
monocytes following pro-inflammatory treatment are different and could be distinguished 
using label-free proteomics. We decided to focuse on one pro-inflammatory stimulus and 
chose LPS as a standard treatment to induce a pro-inflammatory macrophage state (‘1’ in 
Scheme 1). 
Adherent and non-adherent THP-1 cells were collected and analyzed separately after 
incubation with or without LPS (Figure 8A, insert). The proteomes of four subpopulations 
could be distinguished by label-free proteomics and multivariate analysis (Figure 8A), 
supporting the main hypothesis of the study (section 1.2). The analysis of up- and down- 
regulated proteins revealed that the cells remaining in suspension upon LPS treatment were 
activated by cytokines and primed for rapid responsiveness to pathogens (Figure 8B). In 
terms of proteome change, the adhesion process was orthogonal to activation (Figure 8A). 
Adherent cells following LPS treatment exhibited signs of differentiation and enhanced 
innate immune responsivity, suggesting that they were closer to macrophages (Figure 8C). 
These findings indicate that adherent, LPS-treated cells would be more appropriate for use in 
tumor therapeutic applications. Potentially, the cells stimulated with LPS adhere to the 
surface and start producing cytokines, which in turn activates cells remaining in suspension, 
but further studies on primary monocytes are needed to confirm this mechanism. 
Project 1 also addresses a more general question about the role of attachment in 
monocyte differentiation. According to our results, attachment seems to be required for 
differentiation, but on its own, attachment only primes cells, making them more sensitive to 
pro-inflammatory signals (Figure 8D). This conclusion implies that the population of 
adherent cells is a valuable part of the general cell population. It should be collected for 
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proteomics analysis and might be even analyzed separately depending on the focus of the 
investigation. 
 
Figure 8. Summary of the findings in Project 1. (A) Principle component analysis (PCA; R
2
=0.3; 
Q
2
=0.2; four principle components) of proteomics data and schematic overview of the experimental 
design (insert). PCA revealed good reproducibility of biological (grouped by circles) and technical 
(connected by lines unless overlapping) replicates. Untreated Non-adherent cells were used as a 
control population because they stayed in the same morphological state after incubation. Vectors 
connecting UN to LPS-treated Non-adherent (LN) and Untreated Adherent (UA) are almost 
orthogonal suggesting that the proteome changes in these processes are largely independent. (B) 
Selected up-regulated proteins in LN cells (full list in Paper I, Table S5). About 70% of up-regulated 
proteins (listed in bold) are known to be up-regulated in response to cytokines. (C) Markers of 
macrophage differentiation up-regulated in LPS-treated Adherent (LA) cells with fold change values 
in parentheses (full list of up- and down- regulated proteins in LA in Paper I, Table S7). (D) Selected 
up-regulated proteins in UA cells suggested that the cells are primed for pro-inflammatory activation, 
which was also confirmed in additional proteomics experiment (Paper I, Figure 5). 
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2.4.2. Project 2. Assay establishment (Paper I and II) 
The assay is based on comparisons 
between proteomes of monocytes treated 
with a compound of interest and the 
‘reference’ proteomes derived from 
monocytes treated with positive and negative 
controls. The workflow of the assay consists 
of four major steps as depicted in Figure 9.  
The first step is the cell treatment 
and incubation for 48 h with positive and 
negative control stimuli as well as the 
compound(s) of interest. The THP-1 cells 
line was chosen as a model of monocytes. 
Media without treatment was selected as 
negative control. The choice of positive 
controls can be optimized for the particular 
experiment. For establishing the assay we 
focused on two major types of monocyte 
responses we could identify in literature: 
activation (also referred as ‘plasticity’ or 
‘reversible changes’) and differentiation 
(also referred as ‘irreversible changes’). We 
searched for the best positive controls for 
‘pro-inflammatory activation’ among TLR 
ligands and selected PMA as a control for 
‘differentiation’. The proteomics experiment 
supported by cytokine measurement in 
media and cell count results confirmed the 
hypothesis about two major types of 
monocyte responses (Figure 10). Based on 
the results of the experiment PMA was 
selected as a control for differentiation and 
Pam3CSK4 was chosen as the best control 
for pro-inflammatory activation. The 
number and set of the positive controls in the 
particular experiment can be changed and, 
for instance, control for cell death can be 
added in case of toxic compound (see 
section 2.4.3.2) or anti-inflammatory stimuli 
in case such an effect is expected. 
Figure 9. The workflow of the assay 
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The time of incubation is another parameter in the assay that can be optimized 
depending on the stimulus studied. We tested three time points (24, 48 and 72 hours of 
incubation) for selected pro-inflammatory treatments (Pam3CSK4 and LPS). The PCA 
analysis revealed that longer the incubation larger the distance between control and treated 
samples (Paper II, Figure 3). However, the total number of days needed for assay workflow 
increased with longer treatment. We chose 48 hours for general workflow of the assay, which 
seemed to be a reasonable compromise.  
 
Figure 10. THP-1 cells were treated with eight TLR ligands and PMA for 48 h, harvested and 
analyzed using label-free proteomics. OPLS analysis (R
2
=0.628, Q
2
=0.266) revealed two major modes 
of monocyte response, activation and differentiation.  
 
The second step of the assay workflow (‘2’ in Figure 9) starts with cell collection. As 
discussed in Project 1 and confirmed in experiment with TLR ligands and PMA, stimulation 
as well as the negative control results in a mixed population of adherent and non-adherent 
cells, with pro-inflammatory stimuli resulting in a much higher degree of adherence. 
Following the results in Project 1, there two possible approaches to identify the response of 
the monocytic cells. The first approach, in which both adherent and non-adherent cells are 
collected together following stimulation, evaluates the response of the whole cell population. 
The second approach, in which either only adherent or only non-adherent cells are collected, 
would assess the response of the potentially migrating and differentiating cells or activated 
cells, respectively (see section 2.4.3.1). The procedures in the second and third steps in the 
assay workflow (Figure 9, ‘2’ and ‘3’) correspond to preparation and analysis of cell pellets 
using a label-free proteomics approach (also discussed earlier in sections 1.3.2 and 2.3).  
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The final step of the workflow is the bioinformatics analysis (OPLS or PCA). 
Multivariate analysis allows assessing and visualizing the cellular responses to the stimuli of 
interest. The response can not only be characterized, but also estimated. An OPLS model can 
be linearly transformed with negative control set to zero (Paper II, Figure 2B). The distances 
from the origin along the ‘activation’ and the ‘differentiation’ axes could be used to estimate 
the response of THP-1 cells to various stimuli. These results can be also accomplished by 
PTM and pathways analyses to interpret the data and generate hypotheses about the 
mechanism of response. 
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2.4.3. Project 3. Assay applications (Paper II and III) 
The established in Project 2 assay was applied in two studies described below. The 
first was aiming to test whether THP-1 monocytes can recognize presence of post-
translational modification isoaspartate (IsoD) in peptide, while the second one was focused 
on identifying the effects of different nanoparticles on THP-1 monocytes. 
2.4.3.1. Effect of IsoD-containing peptide 
The peptide, with isoaspartate modification, selected as a test compound for the first 
application of the assay, originated from human epidermal growth factor (hEGF). The 
hEGF is a protein that influences cell growth, proliferation, and differentiation cell surface 
receptor EGFR.
73,74
 Recombinant hEGF is used as a drug, in imaging methods and in 
targeted therapies against cancers with over-expression of EGFR.
75,76
 The N-terminal 
sequence of hEGF starts with Asparagine-Serine- (N-S-), a sequence that is prone to rapid 
deamidation. The resultant hEGF with IsoD-S- at the N-terminus has a significantly lower 
affinity to EGFR. Moreover, IsoD in proteins has been reported to be immunogenic and to 
alter autoimmune responses.
77,78
  
We chose the N-terminal hEGF peptide containing the first 19 amino acids of the 
protein with N-terminal asparagine (N) or IsoD to test with the assay. The approach with 
analyzing only adherent THP-1 cells following incubation was applied in this investigation. 
As a result the ‘activation’ and ‘differentiation’ axes were not orthogonal on the OPLS plot 
(Figure 11C, x1 and x2).  
 
Figure 11. Effect of IsoD-containing hEGF peptide on THP-1 cells. The IsoD-peptide induced (A) 
an increase in percentage of adherent cells and (B) decrease in total cell number. (C) The 
proteomics assay was applied to characterize the effect of the IsoD-peptide on adherent THP-1 
cells. The OPLS model revealed that the peptide primes cells for differentiation (x1 axis), but not 
pro-inflammatory activation (x2 axis). The control N-peptide primed cells for activation. 
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The results revealed that the IsoD-peptide primed cells for differentiation, while the 
natural form of the peptide primed cells towards activation (Figure 11C). This conclusion is 
consistent with the result of cell counting. The IsoD-peptide treatment resulted in an 
increase in the fraction of adherent cells and a decrease in the total number of the cells 
compared to control, while neither N- nor D-peptides induced such an effect (Figure 11A 
and 11B). The results of the study imply that the peptides differing in one amino acid can 
be distinguished by monocytes and it can be detected by the established assay. 
2.4.3.2. Effect of Nanoparticles (Au-20-NH2, CdTe-NH2, CuO-core) 
The second application of the assay was on nanoparticles, a rapidly developing group 
of materials as well as environmental contaminants. The estimation and characterization of 
the toxic effects of the nanoparticles is necessary for their safe application and handling. 
Three types of NP with different level of toxicity (different effective concentration, EC50) 
were selected for the study. These NP were cadmium telluride coated with amine group 
(CdTe-NH2), gold NP 20 nm in diameter, also coated with an amine group (Au-20-NH2), and 
cuprum oxide without coating (CuO-core). The effects of these NP on cells have been 
previously studied, but to best of our knowledge have never been combined and compared in 
one proteomics experiment before.  
A positive control for cell death was added in this study. Two anticancer drugs 
(Camptothecin and Doxorubicin) with known mechanisms of action were selected as positive 
controls for cell death due the cancer origin of THP-1 cells (section 1.1.2). The anticancer 
drugs and NP were used at a concentration inducing 50±10% cell death in THP-1 (EC50). The 
lipopolysaccharide (LPS) was used as the positive control for pro-inflammatory activation.  
The strongest effect was induced by CdTe-NH2 NP (Figure 12A). The THP-1 
response to CdTe-NH2 was similar to the Camptothecin effect and both induced down-
regulation of topoisomerases (Figure 12B). The effect of CuO-core combined features of 
THP-1 responses to LPS and Camptothecin. Interestingly, CuO-core induced up-regulation of 
number of heat shock proteins. The response to gold NP could be characterized by up-
regulation of inflammatory mediator NF-κB and a number of protein related to energy 
metabolism, which were also up-regulated in LPS-treated cells.  
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Figure 12. (A) Prediction of the positions of samples on the score plot based on the OPLS model with 
four groups (proteomes of LPS, Doxorubicin and Camptothecin treated cells as well as controls). (B) 
The average relative abundance (log transformed) of Topoisomerase 1 (TOP1) in cells treated with 
Camptothecin, CdTe-NH2, and corresponding controls. 
 
In summary, the applied assay appeared to be an applicable method to characterize 
the effect of NP. This method revealed that the nanoparticles inducing the same phenotypical 
effect (50% dead cells) have different impart on the THP-1 monocyte proteomes. 
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2.4.4. Project 4. Assay extensions and PTM analysis (Paper IV) 
The data obtained in proteomics-based assay can be applied not only to identify 
‘fingerprints’ of stimuli and compare expression of proteins in different treatments but also to 
‘look inside the proteins’ and their changes induced by the stimuli. Project 4 was focused on 
one of the protein modifications occurring in a post-translational modification (PTM) 
process, citrullination.  
Citrulline residues are formed from arginine. The conversion is catalyzed by a family 
of enzymes called peptidylarginine deiminases (Figure 13). Several proteins normally contain 
citrulline in their mature form (e.g., filaggrin, keratin and several histone proteins) while 
other proteins have been shown to be citrullinated during pathological processes, such as 
inflammation and cell death. 
In Project 4 we applied and optimized a direct approach to identify citrullinated 
peptides from LC-MS/MS spectra without prior enrichment or fractionation. Trypsin cleaving 
after arginine or lysine but most likely not after citrulline would generate different peptides 
from citrullinated and unmodified version of a protein. The LysC enzyme was used instead of 
trypsin to be able to identify the modified peptides and compare the modified sites with the 
unmodified ones. Citrullinated peptides can be identified using a search engines such as 
Mascot, yet false positive identifications can be a large problem. Errors in precursor mass can 
lead to false positive results as well as presence of asparagine in the peptide sequence. 
Deamidation of asparagine results in the same mass shift. Manual analysis of spectra was 
used to validate and confirm the citrullinated sites. The markers of citrullination include shift 
in monoisotopic mass with ~1Da, shift in retention time, diagnostic mass shift(s) in MS/MS, 
difference in general MS/MS pattern (Figure 13). The citrullination results in loss of charge 
which leads to changes in hydrophobicity and shift in retention time towards elution of more 
hydrophobic peptides (Figure 13, ‘RT’). Together with a shift in charge state, the distribution 
can validate the modification site in the peptide. 
The approach described above was applied to find a link between lungs and joints in 
development of Rheumatoid Arthritis (RA). RA is an inflammatory autoimmune disease 
affecting joints. There is strong evidence linking RA and citrullination: a significant part of 
RA patients exhibit the presence of anti-citrulline protein/peptide antibodies (ACPAs).
79
 The 
fact that these antibodies appear in the serum before any clinical signs of inflammation in the 
joints indicates that the initial triggering of ACPA production may take place somewhere 
other than the joints. The hypothesis was that the immunological events in the lungs might 
trigger production of ACPA during early RA. To test the hypothesis, the presence of shared 
immunological citrullinated targets in joint and lung biopsies of patients with RA was 
investigated.  
In total 6,790 peptides (non-redundant on sequence level) were identified using the 
Mascot search engine in analyzed biopsies, including 385 potential citrullinated peptides. 
Only 10 candidates were confirmed to be citrullinated, meaning that about 97% of the 
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identified citrullinated peptides were false positive. More than half of the false positive 
peptides (60%) contained asparagine in their sequence. Eight citrullinated peptides were 
found in synovial biopsy specimens and seven were detected in bronchial ones (Paper IV). 
Five of these peptides were shared between the specimens. The identified peptides were 
synthesized and spiked into patient samples for absolute quantification by MS (AQUA 
method). One candidate peptide was synthesized and the presence of antibodies against this 
peptide in patients with RA was confirmed by ELISA.  
 
Figure 13. Example of citrullinated peptide verification and comparison to unmodified pepride with a 
scheme of arginine conversion to citrulline. (1) – unmodified peptide TNPPAGPVRAIAE (m/z = 
646.8517, z = 2, mascot score = 47), (2) – citrullinated pepride TNPPAGPVRAIAE (m/z = 647.3441, 
z = 2, mascot score = 69). Peptides belong to protein PPAD digested by trypsin, GluC and pepsin B. 
 
This study showed that the direct approach with validation can be used to identify 
citrullinated peptides in such complex systems like biopsies. It also gave support to the theory 
that lungs and joints have shared citrullinated epitopes and that RA inflammation might be 
initially starting in other organs than joints.  
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2.5. DISCUSSION 
2.5.1. Assay evaluation 
The main characteristics (section 1.3.1) of an assay, such as specificity, sensitivity, 
reproducibility, limitations and area of application, are discussed in this section in relation 
to the established procedure for identifying monocyte responses.  
The selectivity of the assay refers to the main hypothesis of the study and depends 
on method of detection, monocyte capability to distinguish different substances and the 
uniqueness of the proteome responses. The experiments performed with the project 
confirmed the main hypothesis and showed that the different monocyte proteome responses 
can be detected depending on stimuli the cells were exposed to. The assay was capable to 
reveal that monocytes can detect and distinguish peptides with difference even in one 
amino acid (Paper II, Project 3). 
The sensitivity of the assay similarly to selectivity also depends on the method of 
detection, monocyte sensitivity to compound and monocyte proteome responses to 
compound. Monocytes as part of innate immune system are sensitive and are capable of 
detecting a large variety of compounds. The high sensitivity of MS instruments allows the 
use of low amounts of samples (≈1 µg of protein per sample). Correspondingly, only a 
small number of cells are required (1-3 x 10
5
 cells). The high sensitivity of the assay opens 
the perspective of applying it in clinical settings on human primary monocytes.  
The monocyte proteome response to stimuli was observed to have saturation with 
increasing concentration of the compound and constant time of incubation (Figure 5 in 
Paper I and Figure 3 in Paper II). This observation is consistent with the fact that the 
protein abundances are well-regulated with positive and negative feed-back loops.  The 
synthesis rate is also limited and regulated leading to restriction of protein production. On 
the other side of concertation range, low concentration of a treatment will lead to proteome 
changes induced in a few cells which might not be distinguished in the population. It 
implies that changes in proteomes can be detected within a certain concentration range of 
compounds depending on their potency.  
The effects of the substances are investigated on the level of the cellar population 
instead of individual cells in proteomics. This can lead to a combination of signals from 
different cell subpopulations. However, there are methods to overcome this limitation. The 
separate collection of adherent and non-adherent cells and/or cell sorting by FACS 
separating subpopulations according to specific markers of interest can be used to narrow 
the cell population diversity. Another limitation of the assay is the throughput of 
approximately 2 hours/sample that is common for LC-MS-based proteomics techniques. 
Using proteomics as a detection method require careful quality control to avoid 
false positive results. We suggest using several criteria for assessment of the quality of the 
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proteomics data which has been also described in section 2.3 Materials and Methods in this 
chapter. Comparison of the peptides’ retention times for consistency among different 
samples within the same experiment and assessment of the correlation of the protein 
abundances with the order of injection evaluates the quality of LC. Proteins quantified in 
less than 80% of experiments are less reliable than others and can be excluded from 
analysis. The presence of outliers and position of the replicates on PCA plots shows the 
quality of the experiment in general as well as its reproducibility.  
The reproducibility of the assay can be estimated from the performed experiments 
within the project and can be divided into two parts: reproducibility of the replicates within 
the experiment and reproducibility of the proteome response to a substance between the 
replicate experiments. The first can be evaluated based on the proximity of the replicates 
(biological and technical) on a PCA plot. The quality of technical replicates (same sample 
loaded on instrument twice) was assessed in Project 1 (Figure 8). Samples were loaded in 
random order. All the technical replicates were located close together or overlapped on the 
PCA plot, indicating the quality of the LC-MS/MS analysis was good. In all the performed 
experiments the biological replicates of the proteomes of cells treated with one treatment 
were grouped close together on the PCA plots (e.g. Figure 8, Figure 10) and separated from 
other samples. The reproducibility of the cell response to treatment in different experiments 
can be estimated based on the list of up- and down-regulated proteins found to be 
significant in cell response to a particular treatment. Such a comparison performed in 
Project 1 was concluded to be successful (Paper I). The lists of these proteins are not 
expected to be identical in different experiments, but the presence of key molecules in these 
lists and overlap between them indicate good reproducibility. 
The total number of identified and quantified proteins in our experiments was in a 
range 1.5 – 3.3 ×103. This number was moderate compared to other current publications, 
especially taking into account that no fractionation or labeling was applied prior to LC-MS 
analysis. The goal of the study was not a deep proteomic analysis, but to provide enough 
specificity for reliable OPLS/ PCA separation. For reaching this goal, 3,000 proteins are 
more than enough. This number of proteins is even enough to make hypotheses about the 
mechanism of treatment action. 
2.5.2. Assay applications 
The assessment of the immunogenicity of various compounds is one of the main 
intended applications of the assay. Several modifications in proteins have been shown to 
induce immune response and play role in autoimmune disease (Project 4, Paper IV). In 
Project 3 (Paper II) we investigated the immunogenicity of the IsoD post translational 
modification. The IsoD formation is linked to protein damage and protein structure 
alterations.
80
 IsoD in proteins has also been strongly correlated with development of 
autoimmune diseases
77
 and Alzheimer’s disease81,82. The established assay was applied to 
study the effect of a peptide from the human epidermal growth factor with the first amino 
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acid, N, replaced with IsoD. The cell counting and the assay revealed that the monocytes 
treated with the IsoD-containing peptide were primed for differentiation, but not a pro-
inflammatory response like natural form of the peptide. The cell activation by the natural 
form of the peptide potentially can be explained by the presence of secondary structure in 
peptide and possibly partial binding to the EGF receptor. The priming for monocyte 
differentiation into macrophages by IsoD peptide supports the link between innate 
immunity and neurodegenerative disease, which could be important and intriguing to 
investigate further.  
The estimation of immunogenicity as well as toxicity of newly created substances, 
such as nanoparticles, is an even more important issue.  It is crucial for the protection of 
environment and people working with nanoparticles. The study described in Paper III 
(Project 3) was focused on three nanoparticles with different degrees of toxicity. The toxicity 
was measured in the concentration required to induce 50±10% cell death after 24 h (EC50). 
The CdTe nanoparticles as well as their constituent heavy metal ion Cd
2+
 are known to be 
toxic and revealed response in THP-1 cells similar in magnitude to anticancer drugs. It 
affected topoisomerases, which might indicate that the toxicity mechanism of these 
nanoparticles involves effect on DNA. Indeed, Cd
2+
 ions which can be released from the 
nanoparticles were shown to inhibit the DNA repair mechanisms in the cells.
83
  
CuO-core nanoparticles are less toxic than CdTe-NH2 nanoparticles, and even at a 
higher dose, the effect on the proteome was significantly smaller. The proteins up-regulated 
in CuO-treated cells included four heat shock proteins as well as a number of molecules 
involved in response to unfolded proteins. Such effects could be due to Cu
2+ 
being able to 
substitute in proteins other biologically important dications (Fe
2+
, Mn
+2
, and Mg
2+
), causing 
structural changes in these proteins. Changes induced in extracellular matrix organization, 
similar to LPS treatment, could be due to the monocyte activation as well as in response to 
ROS induced by CuO.  
As opposed to the CuO and CdTe nanoparticles, gold nanoparticles have been shown 
to induce cell death only in particular cases, and their cytotoxicity strongly depends on the 
size and the cover groups.
84,85
 A positive charge on the NP surface (e.g. an amine group as in 
the current study) make them more accessible for the cells. In our study the Au-20-NH2 
nanoparticles induced cell death the in THP-1 cells, and the proteome response was the 
weakest among all tested treatments. It could be that the monocytes can recover after 
exposure to gold nanoparticles
15
 but probably less-so after exposure to other nanoparticles. 
Among the proteins up-regulated in THP-1 after exposure to Au-20-NH2 is the potent 
inflammatory mediator NF-κB, which is also up-regulated in LPS-treated cells. Therefore the 
monocyte response to this nanoparticles seems pro-inflammatory, which is consistent with 
earlier observations that gold nanoparticles induce cytokine release by immune cells.
86,87
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CHAPTER 3. CONCLUSIONS AND FUTURE 
PERSPECTIVES 
We have designed a proteomics-based assay to characterize and estimate the 
monocyte response to various stimuli. The assay is based on comparisons between the 
proteome of cells treated with a compound of interest and reference proteomes. 
The established and validated assay showed that an IsoD-containing peptide primes 
monocytes for differentiation, but does not induce pro-inflammatory activation. The assay 
also showed that the response to CdTe-NH2 is similar to Camptothecin and induced down-
regulation of topoisomeras. The effect of CuO-core combined features of the THP-1 
proteome responses to LPS and Camptothecin as well as induced up-regulation of proteins 
involved in the heat-shock response. The gold nanoparticles induced up-regulation of 
inflammatory mediator NF-κB and a number of proteins related to energy metabolism and 
also up-regulated in LPS-treated cells. 
The developed assay has potential to be extended with analysis of PTMs, such as 
citrullination. There are more possibilities to develop further and extend the assay (Figure 
14). It can be used for further in vitro testing of known as well as novel compounds involved 
in either disease or its treatment by predicting their effect on the human innate immune 
system. The developed approach could be extended and optimized to other innate immune 
cell types, as well as to the secretome of the immune cells instead of their proteome. If the 
hypothesis that there is a link between the sensitivity of monocytes to certain stimuli and the 
risk of certain disease is correct, the assay can be applied to predict patient response to 
treatment. 
 
  
Figure 14. Future developments of the assay. 
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Validation of time of incubation and treatment concentration has been performed. The 
next step of validation could be a comparison between the responses of human primary cells 
and THP-1 cells. This will require samples from a large number of individuals for obtaining 
sufficient statistics to overcome the inevitable bias (e.g. sex, age, race, etc.) and interpersonal 
variability.  
Another approach for further extension of the assay could be to increase the number 
of orthogonal positive controls, e.g. to include anti-inflammatory stimuli or damage-
associated molecular patterns. This addition could increase the number of OPLS dimensions 
characterizing the type of response from two to three or four. The bioinformatics analysis can 
be also optimized and the standard procedure for obtaining a ‘cell response score’ can be 
developed. 
The established assay is flexible and is based on one of the rapidly developing 
techniques, which implies that most likely even more perspectives for the developed 
approach will appear in the nearest future. 
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